John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 40,000 shares at $44.20 ($1.8M) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Seasonal sale ($1.8M) by CHIEF MEDICAL OFFICER — this insider has traded KNSA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.20 | 12,063 | $533K | 29.7% |
| 2 | $44.88 | 22,223 | $997K | 55.6% |
| 3 | $45.92 | 5,714 | $262K | 14.6% |
| Total | $44.82 avg | 40,000 | $1.8M | 100% |
| Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |
| KNSA | SELL | 2024-09-04 | $3.1M | — | Filing → |